Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’s disease and other dementias

Altered blood-brain-barrier function in Alzheimer's disease?

(2010) K. M. Mattila et al.   ACTA NEUROLOGICA SCANDINAVICA

Pigment epithelium-derived factor up-regulation induced by memantine, an N-methyl-d-aspartate receptor antagonist, is involved in increased proliferation of hippocampal progenitor cells

(2010) T. Namba et al.   NEUROSCIENCE

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease

(2009) Alex E. Roher et al.   BIOMARKERS

Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice

(2008) Feng Gu et al.   NEUROSCIENCE LETTERS

Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

(2008) Breno S. O. Diniz et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease

(2007) A.H. Simonsen et al.   NEUROBIOLOGY OF AGING